MedTrace Logo

Gene Polymorphism Associated With Macroangiopathy in Type 2 Diabetes Patients

NCT02882945 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 470

Last updated 2016-08-30

No results posted yet for this study

Summary

To explore the possible implications of HLA-DRB1\*04 alleles in patients with type 2 DM and macroangiopathy

Conditions

  • Diabetic Angiopathies

Interventions

OTHER

Group A

150 healthy blood donors without a family history of diabetes mellitus were enrolled in the study.

OTHER

Group B

200 cases of type 2 DM without complications were enrolled in the study.

OTHER

Group C

120 cases of type 2 DM with macroangiopathy complication were enrolled in the study.. Among the group C subjects, 65 individuals had CHD; 55 patients had cerebrovascular disease (CVD); and 30 subjects had a combination of peripheral vascular diseases (PVD) and CHD.

Sponsors & Collaborators

  • First Affiliated Hospital of Harbin Medical University

    lead OTHER

Principal Investigators

  • Nan Ma, Master · First Affiliated Hospital of Harbin Medical University

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2015-08-31
Completion
2015-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02882945 on ClinicalTrials.gov